The DNA methyltransferase inhibitor SGI-110 effectively aided the differentiation of ALDH+ OCSCs, thereby restoring platinum resensitivity in ovarian cancer cell lines (Wang et al., 2014). This evidence concerns the gene LDHA and ovarian cancer.